Evidence map›Paper›PMID 27071344›Full record

ArticleeLife2016

Time-resolved multimodal analysis of Src Homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases.

Joshua A Jadwin, Dongmyung Oh, Timothy G Curran, Mari Ogiue-Ikeda, Lin Jia, Forest M White, Kazuya Machida, Ji Yu, Bruce J Mayer

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Nanopore-mediated protein delivery enabling three-color single-molecule tracking in living cells.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Src homology 2 domains enhance tyrosine phosphorylationThe Journal of biological chemistry · 2018
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Joshua A JadwinRaymond and Beverly Sackler Laboratory of Molecular Medicine, Department of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, United States.
Dongmyung OhRichard D. Berlin Center for Cell Analysis and Modeling, University of Connecticut School of Medicine, Farmington, United States.
Timothy G CurranDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, United States.
Mari Ogiue-IkedaRaymond and Beverly Sackler Laboratory of Molecular Medicine, Department of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, United States.
Lin JiaRaymond and Beverly Sackler Laboratory of Molecular Medicine, Department of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, United States.
Forest M WhiteDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, United States.
Kazuya MachidaRaymond and Beverly Sackler Laboratory of Molecular Medicine, Department of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, United States.
Ji YuRichard D. Berlin Center for Cell Analysis and Modeling, University of Connecticut School of Medicine, Farmington, United States.
Bruce J MayerRaymond and Beverly Sackler Laboratory of Molecular Medicine, Department of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, United States.ORCID http://orcid.org/0000-0002-4580-3187
University of Connecticut · USMassachusetts Institute of Technology · US

Funding

Dynamics and Topology of Phosphotyrosine-SH2 Interaction NetworksU01CA154966 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MAYER, BRUCE J., WHITE, FOREST M · 2011 to 2015
$2.4M
Bacterial cytoskeletal structures and dynamics at single molecule levelR01GM085301 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI YU, JI · 2009 to 2013
$1.4M
NCI NIH HHS U01 CA154966NCI NIH HHS U01CA154966NIGMS NIH HHS R01 GM085301
6 · The paper itself

Abstract

While the affinities and specificities of SH2 domain-phosphotyrosine interactions have been well characterized, spatio-temporal changes in phosphosite availability in response to signals, and their impact on recruitment of SH2-containing proteins in vivo, are not well understood. To address this issue, we used three complementary experimental approaches to monitor phosphorylation and SH2 binding in human A431 cells stimulated with epidermal growth factor (EGF): 1) phospho-specific mass spectrometry; 2) far-Western blotting; and 3) live cell single-molecule imaging of SH2 membrane recruitment. Far-Western and MS analyses identified both well-established and previously undocumented EGF-dependent tyrosine phosphorylation and binding events, as well as dynamic changes in binding patterns over time. In comparing SH2 binding site phosphorylation with SH2 domain membrane recruitment in living cells, we found in vivo binding to be much slower. Delayed SH2 domain recruitment correlated with clustering of SH2 domain binding sites on the membrane, consistent with membrane retention via SH2 rebinding.

Indexed as

Signal Transductionsrc Homology DomainsBlotting, Far-WesternCell Line, TumorCell MembraneEpidermal Growth FactorEpithelial CellsHumansMass SpectrometryOptical ImagingProtein BindingReceptor Protein-Tyrosine KinasesEpidermal Growth FactorReceptor Protein-Tyrosine Kinasesbiochemistrybiophysicshumanreceptor tyrosine kinaseSH2 domainsignal transductionstructural biology

Identifiers

PMID27071344
PMCPMC4841779
OpenAlexW2338381143

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.